Evaluation of Fracture Risk and Potential Drug Holidays for Postmenopausal Women on Long-Term Bisphosphonate Therapy

International Journal of Women's Health - New Zealand
doi 10.2147/ijwh.s57549
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Long-Term Oral Bisphosphonate Use in Relation to Fracture Risk in Postmenopausal Women With Breast Cancer

Menopause
GynecologyObstetrics
2016English

Long-Term Hormone Replacement Therapy for Postmenopausal Women Raises More Concerns

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative

Journal of the American Geriatrics Society
GerontologyGeriatrics
2017English

Association of Physical Activity and Fracture Risk Among Postmenopausal Women

JAMA network open
Medicine
2019English

Assessment of Non-Vertebral Fracture Risk in Postmenopausal Women

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2007English

Can Bone Turnover Markers Help to Define the Duration of Bisphosphonate Drug Holidays?

Bone Abstracts
2016English

Atypical Insufficiency Fractures Associated With Long-Term Bisphosphonate Therapy: 3 Case Reports

Journal of Bone Biology and Osteoporosis
2015English

Examining Exposure Misclassification of Oral Bisphosphonate Therapy and the Associated Fracture Risk: A Cohort Study

Advances in Pharmacoepidemiology & Drug Safety
2015English

Atypical Bilateral Femur Fractures in a Long-Term Bisphosphonate Therapy: A Case Report

Orthopedic & Muscular System
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy